Pharmacotherapeutic Reports as Tools for Detecting Discrepancies in Continuity of Care

Romero-Ventosa, Elena Yaiza; Gayoso-Rey, Mónica; Samartín-Ucha, Marisol; Lamas-Domínguez, Pablo; Rubianes-González, Martín; Rodríguez-Lorenzo, David; Rodríguez-Vázquez, María Holanda; García-Comesaña, Julio; Piñeiro-Corrales, Guadalupe

doi:10.1177/2168479017716716

Cited by 3 publications

(13 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cohen's kappa coefficient statistic for interrater reliability was 0.46 and 0.62 for the abstract and full-text screening, respectively [6]. Ten studies were ultimately included and are charted in Table 1 [7][8][9][10][11][12][13][14][15][16]. All studies were published in or after the year 2003 [7][8][9][10][11][12][13][14][15][16].…”

Section: Review Review Methodsmentioning

confidence: 99%

“…Ten studies were ultimately included and are charted in Table 1 [7][8][9][10][11][12][13][14][15][16]. All studies were published in or after the year 2003 [7][8][9][10][11][12][13][14][15][16]. Over 80,000 patients living with COPD were represented across all 10 studies [7][8][9][10][11][12][13][14][15][16]; however, over 78,000 patients in this review were those identified in a population-based retrospective cohort of health administrative data in Ontario, Canada [13].…”

Section: Review Review Methodsmentioning

confidence: 99%

“…Thirty-six percent of patients in this pilot study were admitted with COPD as the reason for hospitalization but specific MRPs attributable to COPD hospitalizations were not provided [ 12 ]. In a prospective study conducted in Spain at a large integrated healthcare system, 25% of all MRPs were associated with inhaled medications and were deemed as being related to need, effectiveness, and safety [ 15 ]. This report did not, however, enumerate the counts and frequencies of need, effectiveness, and safety measures specific to inhaled medications [ 15 ].…”

Section: Reviewmentioning

confidence: 99%

“…In a prospective study conducted in Spain at a large integrated healthcare system, 25% of all MRPs were associated with inhaled medications and were deemed as being related to need, effectiveness, and safety [ 15 ]. This report did not, however, enumerate the counts and frequencies of need, effectiveness, and safety measures specific to inhaled medications [ 15 ]. A North Carolina community hospital conducted a retrospective chart review on MRPs in which six MRPs (5.9%) with ICS were all determined to be potentially preventable [ 10 ].…”

Section: Reviewmentioning

confidence: 99%

“…Mitigation strategies to prevent ICS errors in patients living with COPD, such as electronic order sets, interdisciplinary rounds, and pharmacist-led medication reconciliation, have both nominally and statistically reduced ICS errors as reported by four studies in this review [ 8 , 11 , 12 , 16 ]. Three studies in this review reported inhaled medication errors as they pertained to MRPs [ 10 , 12 , 15 ]. The Pharmacy Quality Alliance (PQA) MRP Framework is an evidence-based tool and is familiar to many clinicians [ 19 ].…”

Section: Reviewmentioning

confidence: 99%

See 4 more Smart Citations

Inhaled Medication Errors During Hospitalization or on Hospital Discharge in Patients Living With Chronic Obstructive Pulmonary Disease: A Literature Review

Boylan,

Gibbs,

Helwig

2023

Cureus

View full text Add to dashboard Cite

Inhaled medications, including beta-agonists, muscarinic antagonists, and corticosteroids, are the backbone of chronic obstructive pulmonary disease (COPD) treatment, and pharmacotherapy plans are frequently optimized during and following hospitalization. Clinical practice guidelines acknowledge that patients living with COPD may experience medication errors from inadequate inhaler technique or device faults, but inhaled medication errors within COPD pharmacotherapy plans remain unreported. This literature review aimed to collect and present studies describing medication errors occurring with inhaled medications in patients living with COPD during and following hospitalization. The databases searched included Ovid MEDLINE, Embase, and International Pharmaceutical Abstracts. One hundred forty-five unique studies were collected, and 10 studies were included. The rate of inhaled medication errors reported across the 10 studies ranged between 2.5% and 66% of patients living with COPD and who were hospitalized or discharged. The incidence and types of medication errors reported across the studies varied significantly. Standardization in categorizing and reporting inhaled medication errors is necessary for future studies to determine the true incidence of inhaled medication errors occurring in patients living with COPD who are hospitalized or discharged.

show abstract

Section: Review Review Methodsmentioning

confidence: 99%

Section: Review Review Methodsmentioning

confidence: 99%

Section: Reviewmentioning

confidence: 99%

Section: Reviewmentioning

confidence: 99%

Section: Reviewmentioning

confidence: 99%

See 3 more Smart Citations

Inhaled Medication Errors During Hospitalization or on Hospital Discharge in Patients Living With Chronic Obstructive Pulmonary Disease: A Literature Review

Boylan,

Gibbs,

Helwig

2023

Cureus

View full text Add to dashboard Cite

show abstract

Concordancia de los registros de prescripción de medicamentos en el paciente quirúrgico hospitalizado

Guillén Martínez,

Lucas Mayol,

Rodríguez Morote

et al. 2024

Journal of Healthcare Quality Research

View full text Add to dashboard Cite

Methods used to attribute costs avoided from pharmacist interventions in acute care: A scoping review

Narayan

Abraham

Erstad

et al. 2021

American Journal of Health-System Pharmacy

View full text Add to dashboard Cite

Purpose Cost-avoidance studies are common in pharmacy practice literature. This scoping review summarizes, critiques, and identifies current limitations of the methods that have been used to determine cost avoidance associated with pharmacists’ interventions in acute care settings. Methods An Embase and MEDLINE search was conducted to identify studies that estimated cost avoidance from pharmacist interventions in acute care settings. We included studies with human participants and articles published in English from July 2010 to January 2021, with the intent of summarizing the evidence most relevant to contemporary practice. Results The database search retrieved 129 articles, of which 39 were included. Among these publications, less than half (18 of 39) mentioned whether the researchers assigned a probability for the occurrence of a harmful consequence in the absence of an intervention; thus, a 100% probability of a harmful consequence was assumed. Eleven of the 39 articles identified the specific harm that would occur in the absence of intervention. No clear methods of estimating cost avoidance could be identified for 7 studies. Among all 39 included articles, only 1 attributed both a probability to the potential harm and identified the cost specific to that harm. Conclusion Cost-avoidance studies of pharmacists’ interventions in acute care settings over the last decade have common flaws and provide estimates that are likely to be inflated. There is a need for guidance on consistent methodology for such investigations for reporting of results and to confirm the validity of their economic implications.

show abstract

Pharmacotherapeutic Reports as Tools for Detecting Discrepancies in Continuity of Care

Abstract: A continuity program was implemented based on the drafting of a pharmacotherapeutic report, which allowed for detecting discrepancies and updating the patients' pharmacotherapeutic history, resulting in financial savings after its implementation.

Cited by 3 publications

References 18 publications

Inhaled Medication Errors During Hospitalization or on Hospital Discharge in Patients Living With Chronic Obstructive Pulmonary Disease: A Literature Review

Inhaled Medication Errors During Hospitalization or on Hospital Discharge in Patients Living With Chronic Obstructive Pulmonary Disease: A Literature Review

Concordancia de los registros de prescripción de medicamentos en el paciente quirúrgico hospitalizado

Methods used to attribute costs avoided from pharmacist interventions in acute care: A scoping review

Contact Info

Product

Resources

About